SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001780708-19-000003
Filing Date
2019-06-25
Accepted
2019-06-25 14:17:05
Documents
1
Effectiveness Date
2019-06-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11298
  Complete submission text file 0001780708-19-000003.txt   12368
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 408.809.1030
BioEclipse Therapeutics, Inc. (Filer) CIK: 0001780708 (see all company filings)

IRS No.: 320304849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-342724 | Film No.: 19918126